DRW Research logo
  Home
DRW Research and information services
  Specializing in Regulatory and Biomedical Research

DRW Monthly

Did you miss an issue of DRW Monthly? Click on a date below to read prior issues of this newsletter:

  • December 2006

  • Review of Joint Regulatory Scheme for Proposed Australia New Zealand Therapeutic Products Authority (ANZTPA)

  • January 2007

  • Regulatory Issues Surrounding Genetic Testing in the US

  • February 2007

  • UK Implementation of the EU Directive on Traditional Herbal Medicinal Products

  • March 2007

  • Taiwan Establishes Successful Orphan Drug Program

  • April 2007

  • Developments in the US-Japan "Harmonization By Doing" (HBD) Initiative

  • May 2007

  • The Czech Republic's Harmonization of its Clinical Research Regulations with the EU CTD

  • June 2007

  • EU Approves Regulation on Advanced Therapy Medicinal Products (ATMPs)

  • July 2007

  • Review of FDA/Health Canada's Pilot Multipurpose Audit Program

  • August 2007

  • Compliance Challenges Malaysia faces with Adverse Drug Reporting

  • September 2007

  • Review of Pharmaceutical Advertising Regulations in Canada

  • October 2007

  • Developments in Human Embryonic Stem Cell Research Regulation in Australia

  • November 2007

  • EMEA Introduces EudraGMP Database

  • December 2007

  • Review of FDA's Generic Initiative for Value and Efficiency (GIVE) Program

  • January 2008

  • Update on India's Medical Device Regulations

  • February 2008

  • A Review of FDA Measures to Improve Advisory Committee Processes

  • March 2008

  • Brazilian Medical Device Import Regulations

  • April 2008

  • International Stem Cell Guidelines to be Drafted to Protect Patients

  • May 2008

  • Impact of FDA's Risk Evaluation and Mitigation Strategy (REMS) Requirements on Drug and Biologics Industry

  • June 2008

  • Revisions to China's Medical Device Regulatory System and Reimbursement Issues Impacting Importers

  • July 2008

  • Health Canada's Progress in Regulating Subsequent Entry Biologics: Draft Guidance Issued in March

  • August 2008

  • Argentina Harmonizes Clinical Trial Regulatory Requirements to Conform with International Best Practices

  • September 2008

  • FDA's Pharmaceutical CGMP Initiative to be Implemented in CDER's Office of Biotechnology Products

  • October 2008

  • UK Human Embryology and Fertilisation Bill Passes in House of Commons

  • November 2008

  • Regulatory Paths to Access Unapproved Medicines and Medical Devices in Australia

  • December 2008

  • US and Vietnam Sign Memorandum of Understanding to Enhance Food and Medical Product Import Safety

  • January 2009

  • Japanese Government Adopts Medical Device Approval Action Program

  • February 2009

  • Czech Republic's Healthcare Reforms Result in Drug Reimbursement and Pricing Debates

  • March 2009

  • UK's National Institute for Health and Clinical Excellence to Accelerate Drug Appraisal Process

  • April 2009

  • EU Adopts Classification, Labeling and Packaging Regulation to Align itself with UN's Globally Harmonized System

  • May 2009

  • FDA's Sentinel Initiative to Track Safety of National Drugs, Biologics and Medical Devices

  • June 2009

  • Health Canada Proposes Reforms to its Investigational Device Testing Regulatory Framework

  • July/August 2009

  • ASEAN Economic Ministers Sign Pharmaceutical Trade Agreement and Stanford University Researchers Publish Medical Device Product Development Model

  • September 2009

  • EU to Establish Not-for-Profit International Biobank

  • October 2009

  • Singapore Issues Guidance on Biosimilar Product Registration

  • November 2009

  • Navigating Pharmaceutical Product Registration in the Russian Federation

  • December 2009

  • NHMRC Lifts Ban on Clinical Trials Involving Xenotransplantation in Australia

  • January 2010

  • FDA Partners with Industry Stakeholder to Implement Its Medication Safe Use Initiative


Subscribe today!! Sign up









 

 

 

  2006 © DRW Research & information services, LLC